Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuqian Yan

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Cancer Research|October 8, 2017
Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell InvasionYinhui Yang, Alexandra M Blee, Dejie Wang, et al.
EMBO Molecular Medicine|September 28, 2019
The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancerYuqian Yan, Jian Ma, Dejie Wang, et al.
Molecular Cell|December 12, 2018
Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 ExpressionXin Jin, Donglin Ding, Yuqian Yan, et al.
International Journal of Medical Informatics|February 3, 2024
Methodological challenges in systematic reviews of mHealth interventions: Survey and consensus-based recommendationsJesus Lopez-Alcalde, L Susan Wieland, Jürgen Barth, et al.
Nature Communications|March 31, 2023
TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaksJian Ma, Yingke Zhou, Penglin Pan, et al.
Breast Cancer Research : BCR|January 25, 2011
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancersHuiling Xu, Max Yan, Jennifer Patra, et al.
Molecular Cancer Research : MCR|October 6, 2021
GLI3 Is Stabilized by SPOP Mutations and Promotes Castration Resistance via Functional Cooperation with Androgen Receptor in Prostate CancerMarieke Burleson, Janice J Deng, Tai Qin, et al.
Nature Communications|September 30, 2021
SPOP mutation induces DNA methylation via stabilizing GLP/G9aJianong Zhang, Kun Gao, Hongyan Xie, et al.
BMJ Open|July 25, 2025
Development of a core outcome set for the trials of complementary therapies in people with multiple sclerosis: international survey and consensus meetingsJesus Lopez-Alcalde, Anna K Tietjen, Yuqian Yan, et al.
EMBO Molecular Medicine|March 11, 2018
Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in <i>PTEN</i>- or <i>SPOP</i>-mutated prostate cancerYuqian Yan, Jian An, Yinhui Yang, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Cancer Research|October 8, 2017
Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell InvasionYinhui Yang, Alexandra M Blee, Dejie Wang, et al.
EMBO Molecular Medicine|September 28, 2019
The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancerYuqian Yan, Jian Ma, Dejie Wang, et al.
Molecular Cell|December 12, 2018
Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 ExpressionXin Jin, Donglin Ding, Yuqian Yan, et al.
International Journal of Medical Informatics|February 3, 2024
Methodological challenges in systematic reviews of mHealth interventions: Survey and consensus-based recommendationsJesus Lopez-Alcalde, L Susan Wieland, Jürgen Barth, et al.
Nature Communications|March 31, 2023
TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaksJian Ma, Yingke Zhou, Penglin Pan, et al.
Breast Cancer Research : BCR|January 25, 2011
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancersHuiling Xu, Max Yan, Jennifer Patra, et al.
Molecular Cancer Research : MCR|October 6, 2021
GLI3 Is Stabilized by SPOP Mutations and Promotes Castration Resistance via Functional Cooperation with Androgen Receptor in Prostate CancerMarieke Burleson, Janice J Deng, Tai Qin, et al.
Nature Communications|September 30, 2021
SPOP mutation induces DNA methylation via stabilizing GLP/G9aJianong Zhang, Kun Gao, Hongyan Xie, et al.
BMJ Open|July 25, 2025
Development of a core outcome set for the trials of complementary therapies in people with multiple sclerosis: international survey and consensus meetingsJesus Lopez-Alcalde, Anna K Tietjen, Yuqian Yan, et al.
EMBO Molecular Medicine|March 11, 2018
Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in <i>PTEN</i>- or <i>SPOP</i>-mutated prostate cancerYuqian Yan, Jian An, Yinhui Yang, et al.
Pageof 8